Analysis reveals that nanocarriers enhance drug delivery in kidney disorders, highlighting their potential benefits and challenges.
Nonmaterials incredible ability to deliver drugs to precise locations with little side effects and significant therapeutic results has led to their widespread usage in the field of nanomedicine. When employing nanomedicine to treat kidney problems, it is essential to use carriers with remarkable biocompatibility, such as polymeric nanoparticles, liposomes, nanogel, lipid-based nanocarriers, and nanoparticles. A specific type of carrier is chitosan. The specific renal absorption, extended half-life, and customized organ distribution of these carriers both improve and protect the medication efficacy. It's also important to consider the carriers' toxicity and solubility. There will be an extensive inventory of nanocarrier materials presented, as well as an analysis of the benefits and drawbacks of using them to treat kidney disorders and possible future uses.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: